Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000906:Antibodies; D000941:Antigens; D000961:Antilymphocyte Serum / Q000494:pharmacology; D005528:Foot / Q000473:pathology; D005620:Freund's Adjuvant / Q000494:pharmacology; D006168:Guinea Pigs; D006384:Hemagglutination; D006801:Humans; D006968:Hypersensitivity, Delayed; D007106:Immune Sera; D007165:Immunosuppression Therapy; D007891:Leishmania / Q000472:pathogenicity; D007896:Leishmaniasis / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D009169:Mycobacterium tuberculosis; D011425:Propionibacterium acnes; D014374:Tuberculin Test
D000276:Adjuvants, Immunologic; D000906:Antibodies; D000941:Antigens; D000961:Antilymphocyte Serum; D007106:Immune Sera; D005620:Freund's Adjuvant